Skip to main content
Livermore
Livermore
ZHEN

Brainstorm Cell Therapeutics Inc.

BCLI
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001137883

No open-market purchases or sales by Brainstorm Cell Therapeutics Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

13F holders, Q1 2023

Institutional positions in Brainstorm Cell Therapeutics Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
48
+7 vs. Q4 2022
Shares held
6.36M
+2.67M (+72.6%) vs. Q4 2022
Total value
$20.4M
+$14.3M (+233.3%) vs. Q4 2022
New holders
12
8 more added
Sold out
5
8 more reduced

2 institutions that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting BCLI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2023: 48 institutions
Q1 2021: 75 institutionsQ2 2021: 57 institutionsQ3 2021: 52 institutionsQ4 2021: 42 institutionsQ1 2022: 39 institutionsQ2 2022: 48 institutionsQ3 2022: 42 institutionsQ4 2022: 43 institutionsQ1 2023: 48 institutionsQ2 2023: 57 institutionsQ3 2023: 53 institutionsQ4 2023: 46 institutionsQ1 2024: 47 institutionsQ2 2024: 48 institutionsQ3 2024: 38 institutionsQ4 2024: 34 institutionsQ1 2025: 32 institutionsQ2 2025: 34 institutionsQ3 2025: 5 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ1 2023: $20.4M
Q1 2021: $32.1MQ2 2021: $21.4MQ3 2021: $16.9MQ4 2021: $17.6MQ1 2022: $14.0MQ2 2022: $11.0MQ3 2022: $17.1MQ4 2022: $6.16MQ1 2023: $20.4MQ2 2023: $11.5MQ3 2023: $928.4KQ4 2023: $1.04MQ1 2024: $2.19MQ2 2024: $4.09MQ3 2024: $2.52MQ4 2024: $560.3KQ1 2025: $1.09MQ2 2025: $264.0KQ3 2025: $1.73KQ4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding BCLI and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20255$1.73K
Q2 202534$264.0K
Q1 202532$1.09M
Q4 202434$560.3K
Q3 202438$2.52M
Q2 202448$4.09M
Q1 202447$2.19M
Q4 202346$1.04M
Q3 202353$928.4K
Q2 202357$11.5M
Q1 202348$20.4M
Q4 202243$6.16M
Q3 202242$17.1M
Q2 202248$11.0M
Q1 202239$14.0M
Q4 202142$17.6M
Q3 202152$16.9M
Q2 202157$21.4M
Q1 202175$32.1M

Institutions, Q1 2023

Shares, value and share of portfolio for each institution holding Brainstorm Cell Therapeutics Inc.; share changes are against Q4 2022.

Institutions holding BCLI in Q1 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Caldwell Sutter Capital, Inc.157,009$00.00%+157,009New
NewSquare Capital LLC70$2310.00%00.0%Unchanged
Mark Sheptoff Financial Planning, LLC100$3300.00%00.0%Unchanged
Piershale Financial Group, Inc.100$3300.00%+100New
Westside Investment Management, Inc.200$6600.00%00.0%Unchanged
BNP Paribas Arbitrage, SA364$1.20K0.00%00.0%Unchanged
FMR LLC400$1.32K0.00%+400New
Harbour Investments, Inc.1,475$4.87K0.00%−306−17.2%Reduced
Royal Bank of Canada1,533$5.00K0.00%00.0%Unchanged
Washington Trust Co2,500$8.25K0.00%00.0%Unchanged
Institutional & Family Asset Management, LLC3,000$9.90K0.00%00.0%Unchanged
JPMorgan Chase & Co2,983$10.0K0.00%+2,983New
Bangor Savings Bank4,000$13.2K0.00%00.0%Unchanged
Bank of America Corp4,852$16.0K0.00%−979−16.8%Reduced
UBS Group AG7,500$24.8K0.00%00.0%Unchanged
Steward Partners Investment Advisory, LLC8,200$27.1K0.00%00.0%Unchanged
Tower Research Capital LLC (TRC)8,862$29.0K0.00%+7,806+739.2%Added
Advisor Group Holdings, Inc.10,939$36.0K0.00%−100−0.9%Reduced
Millennium Management LLC11,227$37.0K0.00%−30,391−73.0%Reduced
Raymond James Financial Services Advisors, Inc.11,248$37.1K0.00%+11,248New
Charles Schwab Investment Management Inc11,287$37.2K0.00%00.0%Unchanged
Bank of New York Mellon Corp11,994$39.6K0.00%00.0%Unchanged
XTX Topco Ltd12,227$40.3K0.01%+12,227New
Nelson, Van Denburg & Campbell Wealth Management Group, LLC12,686$41.9K0.00%+12,686New
Citadel Advisors LLC13,168$43.5K0.00%−3,296−20.0%Reduced
Creative Planning13,992$46.2K0.00%−11,689−45.5%Reduced
Boothbay Fund Management, LLC19,098$63.0K0.00%00.0%Unchanged
Wolverine Trading, LLC26,979$67.0K0.00%+26,979New
Wells Fargo & Company24,808$81.9K0.00%+4,937+24.8%Added
Morgan Stanley38,830$128.1K0.00%+14,734+61.1%Added
Jmac Enterprises LLC40,430$133.4K0.03%00.0%Unchanged
Tru Independence Asset Management 2, LLC44,000$145.2K0.15%+44,000New
Northern Trust Corp55,916$184.5K0.00%00.0%Unchanged
Weaver Consulting Group63,713$210.3K0.10%−2,234−3.4%Reduced
State Street Corp96,060$317.0K0.00%00.0%Unchanged
Price T Rowe Associates Inc108,000$357.0K0.00%00.0%Unchanged
Liberty Wealth Management LLC150,400$496.3K0.10%+150,400New
Group One Trading, L.P.162,753$537.1K0.03%+145,775+858.6%Added
Raymond James & Associates164,703$543.5K0.00%−48,000−22.6%Reduced
Simplex Trading, LLC183,390$605.0K0.03%+172,342+1,559.9%Added
Ikarian Capital, LLC189,935$626.8K0.26%00.0%Unchanged
Geode Capital Management, LLC275,706$909.8K0.00%+2,000+0.7%Added
Abner Herrman & Brock LLC280,000$924.0K0.14%00.0%Unchanged
Worth Venture Partners, LLC358,938$1.18M0.58%+358,938New
Susquehanna International Group, LLP401,753$1.33M0.00%+295,682+278.8%Added
BlackRock Inc.474,092$1.56M0.00%+2,320+0.5%Added
Vanguard Group Inc1,428,533$4.71M0.00%00.0%Unchanged
AIGH Capital Management LLC1,459,095$4.82M1.78%+1,459,095New
IFP Advisors, Inc0$00.00%−26,650−100.0%Sold out
Marshall Wace, LLP0$00.00%−37,582−100.0%Sold out
Janney Montgomery Scott LLC0$00.00%−20,000−100.0%Sold out
Jane Street Group, LLC0$00.00%−14,054−100.0%Sold out
Renaissance Technologies LLC0$00.00%−11,800−100.0%Sold out
S.C. Financial Services, Inc.––––Not filed
CoreCap Advisors, LLC––––Not filed